Signal transducers and transcription activators 3 will target the miR-21 promoter according to bioinformatics analysis (STAT3); BBR can inhibit miR-21 transcription in multiple myeloma by downregulating IL-6 through STAT3 downregulation. This evidence concerns the gene STAT3 and plasma cell myeloma.